| Literature DB >> 31454196 |
Qiang Chen1, Ling-Li Yu1, Qi-Liang Zhang1, Hua Cao1, Liang-Wan Chen1, Zhong-Yao Huang1.
Abstract
OBJECTIVE: To analyze and summarize the clinical safety and feasibility of minimally invasive video-assisted mitral valve replacement via a right thoracic minimal incision in patients aged over 65 years.Entities:
Keywords: Heart Valve Diseases; Length of Stay; Mitral Valve; Pneumothorax; Subcutaneous Emphysema; Thoracotomy
Mesh:
Year: 2019 PMID: 31454196 PMCID: PMC6713364 DOI: 10.21470/1678-9741-2018-0409
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Comparison of patients' preoperative general data between the two groups.
| Item | Thoracoscopy-assisted group | Conventional | ||
|---|---|---|---|---|
| Age (years) | 68.3±2.6 | 69.1±3.6 | 0.946 | |
| Gender (male/female) | 08-Dec | Nov-14 | ||
| History of disease (years) | 11.4±5.6 | 13.5±7.3 | 0.602 | |
| BMI | 19.1±2.2 | 18.7±3.1 | 0.911 | |
| NYHA class | I | 3 | 4 | 0.853 |
| II | 8 | 8 | ||
| III | 9 | 13 | ||
| IV | 0 | 0 | ||
| Mitral lesion type | 0.941 | |||
| Mitral stenosis | 5 | 7 | ||
| Mitral regurgitation | 2 | 3 | ||
| Mitral stenosis and regurgitation | 13 | 15 | ||
| Mitral stenosis | Mild | 2 | 2 | 0.966 |
| Moderate | 10 | 13 | ||
| Severe | 6 | 7 | ||
| Mitral regurgitation | Mild | 1 | 2 | 0.730 |
| Moderate | 8 | 11 | ||
| Severe | 6 | 5 | ||
| Moderate or severe tricuspid regurgitation | 13 | 15 | 0.731 | |
| Cardiothoracic ratio | 0.67 ±0.06 | 0.69±0.04 | 0.909 | |
| End-systolic length of the left atrium (mm) | 60.7±5.1 | 63.5±6.2 | 0.821 | |
| End-diastolic length of the left ventricle (mm) | 63.5±8.4 | 65.8±6.7 | 0.716 | |
| End-systolic length of the right atrium (mm) | 71.2±7.3 | 74.5±10.9 | 0.625 | |
| End-diastolic length of the right ventricle (mm) | 39.9±4.8 | 41.7±5.1 | 0.886 | |
| Pulmonary hypertension (mmHg) | 66.5±9.6 | 69.7±11.8 | 0.686 | |
| Ejection fraction (%) | 51.2±6.7 | 49.5±7.7 | 0.837 | |
| Ejection fraction <35% | 0 | 0 | ||
| Atrial fibrillation | 12 | 14 | 0.787 | |
| Left atrial thrombosis | 2 | 4 | 0.556 | |
| Hypertension | 7 | 10 | 0.731 | |
| Diabetes mellitus | 5 | 8 | 0.607 | |
| Hyperlipidemia | 7 | 8 | 0.832 | |
| Aortic disease | 0 | 0 | ||
| Liver insufficiency | 0 | 0 | ||
| Renal insufficiency | 0 | 0 | ||
| Pulmonary infection | 4 | 7 | 0.535 | |
| New cerebral infarction | 0 | 0 | ||
| New cerebral hemorrhage | 0 | 0 | ||
BMI=body mass index; NYHA=New York Heart Association
Comparison of patients' clinical data between the two groups.
| Item | Thoracoscopy-assisted group | Conventional | |
|---|---|---|---|
| Operative time (min) | 148.2±30.9 | 151.5±24.4 | 0.768 |
| Aortic occlusion clamping time (min) | 50.1±12.5 | 43.6±9.7 | 0.815 |
| Cardiopulmonary bypass time (min) | 73.2±13.8 | 68.7±14.9 | 0.713 |
| Incision's length (cm) | 4.8±1.0 | 19.6±1.4 | 0.001 |
| Postoperative mechanical ventilation time (h) | 21.4±6.1 | 23.1±7.8 | 0.677 |
| Postoperative intensive care unit time (days) | 2.2±1.4 | 2.7±1.7 | 0.933 |
| Drainage (ml) | 210.3±60.8 | 510.8±71.3 | 0.011 |
| Blood transfusion volume (ml) | 382.2±56.4 | 718.5±117.8 | 0.009 |
| Postoperative analgesia time (h) | 22.1±5.6 | 48.5±6.4 | 0.023 |
| Postoperative hospital length of stay (days) | 10.5±2.9 | 14.2±2.1 | 0.047 |
| Hospital costs (10000RMB | 9.1±1.1 | 8.7±1.7 | 0.958 |
Costs in renminbi (the Chinese currency)
Comparison of postoperative complications between the two groups.
| Item | Thoracoscopy-assisted group | Conventional | |
|---|---|---|---|
| Death | 0 | 0 | |
| Cerebral infarction | 0 | 0 | |
| Cerebral hemorrhage | 0 | 0 | |
| Recovery delay | 0 | 0 | |
| Heart failure | 0 | 0 | |
| Malignant arrhythmia | 0 | 0 | |
| Liver insufficiency | 1 | 1 | |
| Acute renal insufficiency | 2 | 3 | 0.633 |
| Pulmonary insufficiency | 1 | 1 | |
| Gastrointestinal bleeding | 1 | 1 | |
| Pulmonary infection | 4 | 13 | 0.028 |
| Reoperation for bleeding | 0 | 3 | |
| Poor wound healing | 1 | 7 | 0.045 |
| Pneumothorax | 4 | 0 | 0.019 |
| Subcutaneous emphysema | 3 | 0 | 0.045 |
| Perivalvular leakage | 0 | 0 | |
| Mechanical valve flap | 0 | 0 |
Comparison of preoperative and postoperative renal function between the two groups.
| Item | Thoracoscopy-assisted group | Conventional | |
|---|---|---|---|
| Preoperative creatinine (umol/L) | 98.6±12.3 | 105.7±15.4 | 0.675 |
| Preoperative kidney GFR (ml/min) | 54.4±6.3 | 51.7±7.6 | 0.802 |
| Creatinine in the 1st postoperative day (umol/L) | 221.4±21.5 | 239.6±32.1 | 0.823 |
| Creatinine in the 3rd postoperative day (umol/L) | 146.8±31.4 | 151.5±44.9 | 0.875 |
| Creatinine in the 7th postoperative day (umol/L) | 103.4±12.7 | 108.9±15.1 | 0.916 |
| Creatinine in the 10th postoperative day (umol/L) | 99.7±14.2 | 100.5±13.4 | 0.936 |
GFR=glomerular filtration rate
One-year follow-up echocardiographic data comparison between two group of patients.
| Item | Thoracoscopy-assisted group | Conventional | |
|---|---|---|---|
| End-systolic length of the left atrium (mm) | 45.6±5.4 | 47.4±6.5 | 0.877 |
| End-diastolic length of the left ventricle (mm) | 53.4±4.3 | 54.2±5.5 | 0.923 |
| End-systolic length of the right atrium (mm) | 41.1±5.2 | 45.6±6.7 | 0.881 |
| End-diastolic length of the right ventricle (mm) | 34.4±4.1 | 36.9±5.1 | 0.867 |
| Ejection fraction (%) | 58.8±7.3 | 55.4±8.4 | 0.812 |
| Pulmonary hypertension (mmHg) | 30.2±9.9 | 27.5±11.2 | 0.654 |
| Max MV PG (mmHg) | 10.3±1.8 | 11.5±2.3 | 0.956 |
| Mechanical valve flap | 0 | 0 | |
| Perivalvular leakage | 0 | 0 |
MV=mitral valve; PG=peak gradient
| Abbreviations, acronyms & symbols | |
|---|---|
| BMI | = Body mass index |
| CPB | = Cardiopulmonary bypass |
| EF | = Ejection fraction |
| GFR | = Glomerular filtration rate |
| MV | = Mitral valve |
| NYHA | = New York Heart Association |
| PG | = Peak gradient |
| SPSS | = Statistical Package for the Social Sciences |
| TTE | = Transthoracic echocardiography |
| Author's roles & responsibilities | |
|---|---|
| QC | Substantial contributions to the conception or design of the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| LLY | Final approval of the version to be published |
| QLZ | Final approval of the version to be published |
| HC | Final approval of the version to be published |
| LWC | Final approval of the version to be published |
| ZYH | Substantial contributions to the conception or design of the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |